Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Cancer Research UK
Carevive Systems, Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Royal Marsden NHS Foundation Trust
University of Nebraska
Adela, Inc
Mayo Clinic
University Health Network, Toronto
Cancer Research UK
Incyte Corporation
University of Alabama at Birmingham
Baxter Healthcare Corporation
Compugen Ltd